Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
Cholangiocarcinoma (CCA) is one of the most lethal cancers, and its rate of occurrence is increasing annually. The diagnoses of CCA patients remain elusive due to the lack of early symptoms and is misdiagnosed as HCC in a considerable percentage of patients. It is crucial to explore the underlying m...
Main Authors: | Kishor Pant, Seth Richard, Estanislao Peixoto, Sergio A Gradilone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2020.00113/full |
Similar Items
-
Single-Cell Transcriptional Profiling of Cells Derived From Regenerating Alveolar Ducts
by: Alexandra B. Ysasi, et al.
Published: (2020-04-01) -
SIRT3 elicited an anti‐Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis
by: Lei Xu, et al.
Published: (2019-05-01) -
Metabolic reprogramming in triple-negative breast cancer
by: Zhanyu Wang, et al.
Published: (2020-02-01) -
Regulation of Metabolic Reprogramming by Long Non-Coding RNAs in Cancer
by: Assunta Sellitto, et al.
Published: (2021-07-01) -
Metabolic Reprogramming, Questioning, and Implications for Cancer
by: Pierre Jacquet, et al.
Published: (2021-02-01)